NutriBand (NTRB) Asset Utilization Ratio (2019 - 2026)
NutriBand (NTRB) posted Asset Utilization Ratio of 0.25 for Q2 2026, down 2.13% sequentially from 0.26 in Q1 2026, and down 29.1% YoY from 0.35 in Q2 2025.
NutriBand (NTRB) Asset Utilization Ratio (2019 - 2026) Analysis & Trends
NutriBand has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.25 in Q2 2026.
- Quarterly Asset Utilization Ratio fell 29.1% year-over-year to 0.25 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 0.25 (down 29.1% YoY) and the FY2026 annual result came in at 0.27, down 5.0% from the prior year.
- Asset Utilization Ratio fell to 0.25 in Q2 2026 per NTRB's latest filing, from 0.26 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.35 in Q2 2025 and troughed at 0.1 in Q1 2022.
- A 5-year average of 0.21 and a median of 0.22 in 2023 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio tumbled 48.99% in 2024, then surged 151.98% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.19 in 2022, then grew by 22.5% to 0.23 in 2023, then plunged by 31.96% to 0.15 in 2024, then jumped by 58.63% to 0.25 in 2025, then increased by 1.89% to 0.25 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.25, 0.26, and 0.25 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 | 0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 0.25 |
| Jan 31, 2026 | 0.26 |
| Oct 31, 2025 | 0.25 |
| Jul 31, 2025 | 0.32 |
| Apr 30, 2025 | 0.35 |
| Jan 31, 2025 | 0.21 |
| Oct 31, 2024 | 0.15 |
| Jul 31, 2024 | 0.13 |
| Apr 30, 2024 | 0.18 |
| Jan 31, 2024 | 0.26 |
| Oct 31, 2023 | 0.23 |
| Jul 31, 2023 | 0.25 |
| Apr 30, 2023 | 0.23 |
| Jan 31, 2023 | 0.21 |
| Oct 31, 2022 | 0.19 |
| Jul 31, 2022 | 0.15 |
| Apr 30, 2022 | 0.12 |
| Jan 31, 2022 | 0.10 |
| Oct 31, 2021 | 0.08 |
| Jul 31, 2021 | 0.11 |